NCT05822219

Brief Summary

To establish the efficacy of a community-based POL (Popular Opinion Leader) intervention with two different trainings designed to increase COVID-19 vaccine and booster uptake and reduce hesitancy among social networks of Black individuals with rheumatic conditions. The investigators will also determine the structure and composition of the personal and outreach social networks of POLs.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
11mo left

Started Mar 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Mar 2024Mar 2027

First Submitted

Initial submission to the registry

March 20, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 20, 2023

Completed
11 months until next milestone

Study Start

First participant enrolled

March 15, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2027

Expected
Last Updated

April 6, 2025

Status Verified

February 1, 2025

Enrollment Period

2 years

First QC Date

March 20, 2023

Last Update Submit

April 3, 2025

Conditions

Keywords

Social networkCommunity based interventionVaccine uptakePopular Opinion Leaders

Outcome Measures

Primary Outcomes (1)

  • Receipt of >1 COVID-19 vaccine or booster dose

    This will be measured as documentation of receipt of \>1 additional COVID-19 vaccine or booster dose above network members' baseline number of doses, scored yes or no.

    6 months

Secondary Outcomes (2)

  • Change in COVID-19 vaccine hesitancy

    6 months

  • Structure and composition of the Popular Opinion Leader outreach networks.

    6 months

Study Arms (2)

COVID-19 vaccine and booster training

ACTIVE COMPARATOR

Group training involving COVID-19 vaccine and booster information, including background, development, and myths.

Behavioral: COVID-19 vaccine and booster training, and importance

COVID-19 vaccine and booster training with extra undisclosed component

EXPERIMENTAL

Group training involving COVID-19 vaccine and booster information, including background, development, and myths. Contains extra training component that is undisclosed until the end of the study so as not to introduce bias.

Behavioral: COVID-19 vaccine and booster training, and importance

Interventions

COVID-19 vaccine and booster information training

COVID-19 vaccine and booster trainingCOVID-19 vaccine and booster training with extra undisclosed component

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • POLs:
  • years old; All genders; English-speaking; Self-identify as Black and/or African descent; Received ≥1 dose of a COVID-19 vaccine after 8.31.2022 (bivalent booster or updated COVID-19 vaccine \[2023-2024\] formula)
  • Social network members:
  • At least 18 years of age; All genders; English-speaking or Haitian Creole or Spanish-speaking if the POL also speaks Haitian Creole or Spanish; Not have received the updated COVID-19 vaccine 2023-2024 formula; Recent (within 3 months) COVID-19 infection and either undecided or no intention of receiving the vaccine.

You may not qualify if:

  • Both POLs and social network members:
  • Under 18 years of age Pregnant women Institutionalized or incarcerated Those who are up to date on COVID vaccinations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern University

Chicago, Illinois, 60611, United States

Location

Related Publications (2)

  • Sirek G, Erickson D, Muhammad LN, Losina E, Chandler MT, Son MB, Crespo-Bosque M, York M, Jean-Jacques M, Milaeger H, Pillai N, Roberson T, Chung A, Shramuk M, Osaghae E, Williams J, Ojikutu BO, Dhand A, Ramsey-Goldman R, Feldman CH. Community-engaged randomised controlled trial to disseminate COVID-19 vaccine-related information and increase uptake among Black individuals in two US cities with rheumatic conditions. BMJ Open. 2024 Aug 24;14(8):e087918. doi: 10.1136/bmjopen-2024-087918.

  • Sirek G, Ulysse S, Jacques Toussaint M, Nosamiefan C, Desrosiers L, Chandler M, Ramsey-Goldman R, Fleurissaint DJ, Feldman CH. A community-engaged approach to translate a Vaccine Hesitancy Scale into Haitian Creole. Vaccine. 2024 Apr 2;42(9):2127-2134. doi: 10.1016/j.vaccine.2024.02.079. Epub 2024 Mar 7.

MeSH Terms

Conditions

Rheumatic DiseasesCOVID-19

Interventions

COVID-19 Vaccines

Condition Hierarchy (Ancestors)

Musculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Viral VaccinesVaccinesBiological ProductsComplex Mixtures

Study Officials

  • Rosalind Ramsey-Goldman, MD, DrPH

    Northwestern University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participants are unblinded but study has non-disclosure component of keeping the difference between the two training arms as non-disclosed until the conclusion of the study.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Two different group training arms related to COVID-19 vaccine uptake
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator - Chicago

Study Record Dates

First Submitted

March 20, 2023

First Posted

April 20, 2023

Study Start

March 15, 2024

Primary Completion

March 31, 2026

Study Completion (Estimated)

March 30, 2027

Last Updated

April 6, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

The final data sets from this project will include participant reported survey outcomes and will be de-identified in accordance with HIPAA guidelines. Several methods of resource sharing will be employed by this project including:1)Publishing of results in scientific journals and presentation at professional meetings 2)Replies to requests from individuals for data, and sent via secure methods such as password protected files 3)Posting of POL training curriculum after all data are collected on Dr. Ramsey-Goldman's (MPI) NU webpage 4)Posting study-specific adaptations made to social network survey on website of Dr. Dhand (Co-Investigator).

Shared Documents
STUDY PROTOCOL
Time Frame
Resource sharing will be made available in a timely manner and no later than 12 months after the publication of the main findings from the final data set.
Access Criteria
Any investigator who wishes to obtain data from this Project will do so with a Resource Sharing Agreement that provides for 1) a commitment to using the resources only for research purposes and not to identify an individual participant.2) a commitment to securing resources using appropriate computer technology.3) a commitment to destroy or return the resources after analyses are completed.4) cover the cost of preparing data including programming time and other tasks required to transfer the dataset.

Locations